Belite Bio (BLTE) Operating Leases (2022 - 2025)

Belite Bio's Operating Leases history runs 4 years deep, the most recent figure standing at $188000.0 for Q4 2025.

• On a quarterly basis, Operating Leases fell 27.97% year-over-year to $188000.0 in Q4 2025; TTM through Dec 2025 was $188000.0, a 27.97% decrease from a year earlier, with the FY2025 full-year figure at $188000.0, down 27.97% from the prior year.
• Operating Leases retreated to $188000.0 in Q4 2025 per BLTE's latest filing, from $245000.0 in the prior quarter.
• Across five years, Operating Leases topped out at $668000.0 in Q4 2022 and bottomed at $188000.0 in Q4 2025.
• The 4-year median for Operating Leases is $261000.0 (2024), against an average of $388000.0.
• Across the five-year window, Operating Leases fell 13.47% in 2023 and plunged 54.84% in 2024, its largest moves.
• Year by year, Operating Leases stood at $668000.0 in 2022, then decreased by 13.47% to $578000.0 in 2023, then plunged by 54.84% to $261000.0 in 2024, then retreated by 27.97% to $188000.0 in 2025.
• Per Business Quant, the three latest BLTE Operating Leases figures stand at $188000.0 (Q4 2025), $245000.0 (Q3 2025), and $261000.0 (Q4 2024).